Results 271 to 280 of about 73,124 (298)
Some of the next articles are maybe not open access.
Pulmonary rehabilitation in idiopathic pulmonary fibrosis
Current Opinion in Pulmonary MedicinePurpose of review This review synthesizes the expanding evidence for pulmonary rehabilitation that has led to its recommended inclusion in the holistic care of people with idiopathic pulmonary fibrosis (IPF), as well as discussing strategies that may maximize and sustain benefits.
Leona M, Dowman, Anne E, Holland
openaire +2 more sources
Imaging of Idiopathic Pulmonary Fibrosis
Radiologic Clinics of North America, 2016Idiopathic interstitial pneumonias are a heterogeneous group of diffuse lung diseases characterized by distinct clinicopathologic entities with the usual interstitial pneumonia (UIP) being the most common. The pattern of UIP can be seen in idiopathic pulmonary fibrosis (IPF) as well as in secondary causes, most commonly in connective tissue diseases ...
Joanna E, Kusmirek +2 more
openaire +2 more sources
Idiopathic pulmonary fibrosis in infants
Pediatric Pulmonology, 1997Idiopathic pulmonary fibrosis is a poorly characterized disease in infants. In the present report, we reviewed our experience with 10 infants during a 10-year period. In 9 patients, onset of symptoms occurred before the age of 2 months and included tachypnea, cough, and inadequate weight gain.
E, Osika +8 more
openaire +2 more sources
MicroRNAs in idiopathic pulmonary fibrosis
Translational Research, 2011In this review, we describe the recent advances in the understanding of the role of microRNAs in idiopathic pulmonary fibrosis (IPF), a chronic progressive and lethal fibrotic lung disease. Approximately 10% of the microRNAs are significantly changed in IPF lungs.
Kusum V, Pandit +2 more
openaire +2 more sources
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
New England Journal of Medicine, 2022Luca Richeldi +2 more
exaly
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine, 2018Ganesh Raghu +2 more
exaly
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
New England Journal of Medicine, 2011Luca Richeldi +2 more
exaly